Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3355

Actual shortage: 217 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

61 (25%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-WARFARIN 5MG TABLET Resolved 2020-07-08 2020-09-21 119773
APO-WARFARIN 5MG TABLET Resolved 2020-07-29 2020-09-21 121343
APO-WARFARIN 5MG TABLET Resolved 2020-10-21 2020-12-28 126780
APO-ZOLMITRIPTAN 2.5MG TABLET Resolved 2017-10-12 2018-02-26 25646
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-12 2018-09-12 25649
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-08 2024-02-23 212934
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-01-16 2025-02-07 247880
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-09-30 2020-11-19 125369
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-10-21 2020-11-19 126783
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-10-04 2024-12-06 239364
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-10-18 2024-10-25 240639
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-03-27 2020-05-11 109689
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-01 2020-05-11 110342
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-02-23 214235
APO-ZOPICLONE 5MG TABLET Resolved 2023-12-15 2024-02-23 213565
APO-ZOPICLONE 7.5MG TABLET Resolved 2023-12-22 2024-02-23 214229
APO-ZOPICLONE 7.5MG TABLET Resolved 2023-11-10 2023-11-24 209933
APO-ZOPICLONE 5MG TABLET Resolved 2017-09-04 2018-01-19 20915

Showing 3241 to 3260 of 3355

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-LEVOCARB 25MG 250MG TABLET Discontinued 2018-09-07 2019-02-07 60576
APO-LISINOPRIL 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-LISINOPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-LOPERAMIDE 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-LOSARTAN 50MG TABLET Discontinued 2018-09-10 2018-09-15 60987
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603

Showing 201 to 220 of 359